Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NCAM1 ELISA Kit (AC3243)
Cat.#: ASET-1832
Specifications
Description Human NCAM1 ELISA Kit allows for the in vitro quantitative determination of human NCAM1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1197 Human EMP3 ELISA Kit (AC2608) Quantitative inquiry ASET-2459 Mouse ATG9A ELISA Kit (AC3870) Quantitative inquiry ASET-2114 Human SPON2 ELISA Kit (AC3525) Quantitative inquiry ASET-1393 Human Synaptophysin ELISA Kit (AC2804) Quantitative inquiry ASET-2299 Human FGF13 ELISA Kit (AC3710) Quantitative inquiry ASET-1884 Human LMX1b ELISA Kit (AC3295) Quantitative inquiry ASET-2172 Human Parkin ELISA Kit (AC3583) Quantitative inquiry ASET-1701 Rat CACNA1A ELISA Kit (AC3112) Quantitative inquiry ASET-2291 Human Wnt5a ELISA Kit (AC3702) Quantitative inquiry ASET-2025 Human HNT ELISA Kit (AC3436) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket